Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway

Diabetic neuropathy is a chronic condition that affects a significant number of individuals with diabetes. Streptozotocin injection intraperitoneally to rodents produces pancreatic islet β-cell destruction causing hyperglycemia, which affect the brain leading to memory and cognition impairment. Dapa...

Full description

Bibliographic Details
Main Authors: Hala El-Safty, Ashraf Ismail, Rania M. Abdelsalam, Ayman E. El-Sahar, Muhammed A. Saad
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Brain Research Bulletin
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0361923022000260
_version_ 1797367836694282240
author Hala El-Safty
Ashraf Ismail
Rania M. Abdelsalam
Ayman E. El-Sahar
Muhammed A. Saad
author_facet Hala El-Safty
Ashraf Ismail
Rania M. Abdelsalam
Ayman E. El-Sahar
Muhammed A. Saad
author_sort Hala El-Safty
collection DOAJ
description Diabetic neuropathy is a chronic condition that affects a significant number of individuals with diabetes. Streptozotocin injection intraperitoneally to rodents produces pancreatic islet β-cell destruction causing hyperglycemia, which affect the brain leading to memory and cognition impairment. Dapagliflozin may be able to reverse beta-cell injury and alleviate this impairment. This effect may be via neuroprotective effect or possible involvement of the antioxidant, and anti-apoptotic properties. Forty rats were divided into four groups as follows: The normal control group, STZ-induced diabetes group, STZ-induced diabetic rats followed by treatment with oral dapagliflozin group and normal rats treated with oral dapagliflozin. Behavioral tests (Object location memory task and Morris water maze) were performed. Serum biomarkers (blood glucose and insulin) were measured and then the homeostatic model assessment for insulin resistance (HOMA-IR) was calculated. In the hippocampus the followings were determined; calmodulin, ca-calmodulin kinase Ⅳ (CaMKIV), protein kinase A (PKA) and cAMP-responsive element-binding protein to determine the transcription factor CREB and its signaling pathway also Wnt signaling pathway and related parameters (WnT, B-catenin, lymphoid enhancer binding factor LEF, glycogen synthase kinase 3β). Moreover, nuclear receptor-related protein-1, acetylcholine and its hydrolyzing enzyme acetylcholine esterase, oxidative stress parameter malondialdehyde (MDA) and apoptotic parameter caspase-3 were determined. STZ was able to cause destruction to pancreatic β-cells which was reflected on glucose levels causing diabetes. Diabetic neuropathy was clear in the rats performing the behavioral tests. Memory and cognition parameters in the hippocampus were negatively affected. Oxidative stress and apoptotic parameter were elevated while the electrical activity was declined. Dapagliflozin was able to reverse the previously mentioned parameters and behavior. Thus, to say dapagliflozin significantly showed neuroprotective action along with antioxidant, and anti-apoptotic properties.
first_indexed 2024-03-08T17:22:49Z
format Article
id doaj.art-8b62c5088fb040a2a2008f489299a00f
institution Directory Open Access Journal
issn 1873-2747
language English
last_indexed 2024-03-08T17:22:49Z
publishDate 2022-04-01
publisher Elsevier
record_format Article
series Brain Research Bulletin
spelling doaj.art-8b62c5088fb040a2a2008f489299a00f2024-01-03T04:11:12ZengElsevierBrain Research Bulletin1873-27472022-04-01181109120Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathwayHala El-Safty0Ashraf Ismail1Rania M. Abdelsalam2Ayman E. El-Sahar3Muhammed A. Saad4National Institute of Diabetes and Endocrinology, Cairo, Egypt; Corresponding author.Research and Training Center, National Institute of Diabetes and Endocrinology, Cairo, EgyptDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt; School of Pharmacy, Newgiza University, Cairo, EgyptDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, EgyptDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt; School of Pharmacy, Newgiza University, Cairo, EgyptDiabetic neuropathy is a chronic condition that affects a significant number of individuals with diabetes. Streptozotocin injection intraperitoneally to rodents produces pancreatic islet β-cell destruction causing hyperglycemia, which affect the brain leading to memory and cognition impairment. Dapagliflozin may be able to reverse beta-cell injury and alleviate this impairment. This effect may be via neuroprotective effect or possible involvement of the antioxidant, and anti-apoptotic properties. Forty rats were divided into four groups as follows: The normal control group, STZ-induced diabetes group, STZ-induced diabetic rats followed by treatment with oral dapagliflozin group and normal rats treated with oral dapagliflozin. Behavioral tests (Object location memory task and Morris water maze) were performed. Serum biomarkers (blood glucose and insulin) were measured and then the homeostatic model assessment for insulin resistance (HOMA-IR) was calculated. In the hippocampus the followings were determined; calmodulin, ca-calmodulin kinase Ⅳ (CaMKIV), protein kinase A (PKA) and cAMP-responsive element-binding protein to determine the transcription factor CREB and its signaling pathway also Wnt signaling pathway and related parameters (WnT, B-catenin, lymphoid enhancer binding factor LEF, glycogen synthase kinase 3β). Moreover, nuclear receptor-related protein-1, acetylcholine and its hydrolyzing enzyme acetylcholine esterase, oxidative stress parameter malondialdehyde (MDA) and apoptotic parameter caspase-3 were determined. STZ was able to cause destruction to pancreatic β-cells which was reflected on glucose levels causing diabetes. Diabetic neuropathy was clear in the rats performing the behavioral tests. Memory and cognition parameters in the hippocampus were negatively affected. Oxidative stress and apoptotic parameter were elevated while the electrical activity was declined. Dapagliflozin was able to reverse the previously mentioned parameters and behavior. Thus, to say dapagliflozin significantly showed neuroprotective action along with antioxidant, and anti-apoptotic properties.http://www.sciencedirect.com/science/article/pii/S0361923022000260Diabetic neuropathyMemory and cognitionDapagliflozinWnt/β-cateninCREB
spellingShingle Hala El-Safty
Ashraf Ismail
Rania M. Abdelsalam
Ayman E. El-Sahar
Muhammed A. Saad
Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway
Brain Research Bulletin
Diabetic neuropathy
Memory and cognition
Dapagliflozin
Wnt/β-catenin
CREB
title Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway
title_full Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway
title_fullStr Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway
title_full_unstemmed Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway
title_short Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway
title_sort dapagliflozin diminishes memory and cognition impairment in streptozotocin induced diabetes through its effect on wnt β catenin and creb pathway
topic Diabetic neuropathy
Memory and cognition
Dapagliflozin
Wnt/β-catenin
CREB
url http://www.sciencedirect.com/science/article/pii/S0361923022000260
work_keys_str_mv AT halaelsafty dapagliflozindiminishesmemoryandcognitionimpairmentinstreptozotocininduceddiabetesthroughitseffectonwntbcateninandcrebpathway
AT ashrafismail dapagliflozindiminishesmemoryandcognitionimpairmentinstreptozotocininduceddiabetesthroughitseffectonwntbcateninandcrebpathway
AT raniamabdelsalam dapagliflozindiminishesmemoryandcognitionimpairmentinstreptozotocininduceddiabetesthroughitseffectonwntbcateninandcrebpathway
AT aymaneelsahar dapagliflozindiminishesmemoryandcognitionimpairmentinstreptozotocininduceddiabetesthroughitseffectonwntbcateninandcrebpathway
AT muhammedasaad dapagliflozindiminishesmemoryandcognitionimpairmentinstreptozotocininduceddiabetesthroughitseffectonwntbcateninandcrebpathway